The Archive · A Source
FLT3 inhibitor approved for rel/ref AML in Japan
MDedge Hematology and Oncology 2018 www.mdedge.com/hematology-oncology/article/184689/leukemia-myelodysplasia-transplantation/flt3-inhibitor-approved-rel/ref-aml
An Independent Reference on Medical Travel Abroad · Reader-Funded
The Archive · A Source
MDedge Hematology and Oncology 2018 www.mdedge.com/hematology-oncology/article/184689/leukemia-myelodysplasia-transplantation/flt3-inhibitor-approved-rel/ref-aml